ES2053585T3 - Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina. - Google Patents

Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.

Info

Publication number
ES2053585T3
ES2053585T3 ES87810723T ES87810723T ES2053585T3 ES 2053585 T3 ES2053585 T3 ES 2053585T3 ES 87810723 T ES87810723 T ES 87810723T ES 87810723 T ES87810723 T ES 87810723T ES 2053585 T3 ES2053585 T3 ES 2053585T3
Authority
ES
Spain
Prior art keywords
interferon
bovine
bovino
alfa
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87810723T
Other languages
English (en)
Spanish (es)
Inventor
Kevin Anderson
Lorne Babiuk
Joseph Stephen Mccracken
Helle Bielefeldt Ohmann
John Philip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2053585T3 publication Critical patent/ES2053585T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES87810723T 1986-12-12 1987-12-07 Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina. Expired - Lifetime ES2053585T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94145386A 1986-12-12 1986-12-12
US11784087A 1987-11-13 1987-11-13

Publications (1)

Publication Number Publication Date
ES2053585T3 true ES2053585T3 (es) 1994-08-01

Family

ID=26815704

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87810723T Expired - Lifetime ES2053585T3 (es) 1986-12-12 1987-12-07 Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.

Country Status (10)

Country Link
EP (1) EP0271447B1 (US07118763-20061010-C00002.png)
JP (1) JPH0725694B2 (US07118763-20061010-C00002.png)
AU (1) AU609435B2 (US07118763-20061010-C00002.png)
CA (1) CA1329122C (US07118763-20061010-C00002.png)
DE (1) DE3784650D1 (US07118763-20061010-C00002.png)
ES (1) ES2053585T3 (US07118763-20061010-C00002.png)
GR (1) GR3007798T3 (US07118763-20061010-C00002.png)
IE (1) IE59917B1 (US07118763-20061010-C00002.png)
IL (1) IL84777A (US07118763-20061010-C00002.png)
NZ (1) NZ222875A (US07118763-20061010-C00002.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5049378A (en) * 1989-04-24 1991-09-17 Ciba-Geigy Canada Ltd. Prevention and treatment of porcine haemophilus pneumonia (PHP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
AU588332B2 (en) * 1986-07-04 1989-09-14 Tachi-S Co., Ltd. Seat suspension device

Also Published As

Publication number Publication date
AU8246687A (en) 1988-06-16
GR3007798T3 (US07118763-20061010-C00002.png) 1993-08-31
CA1329122C (en) 1994-05-03
IE873366L (en) 1988-06-12
NZ222875A (en) 1990-10-26
EP0271447A2 (de) 1988-06-15
JPS63239235A (ja) 1988-10-05
IL84777A0 (en) 1988-05-31
IL84777A (en) 1992-12-01
IE59917B1 (en) 1994-04-20
EP0271447B1 (de) 1993-03-10
EP0271447A3 (en) 1989-03-08
AU609435B2 (en) 1991-05-02
DE3784650D1 (de) 1993-04-15
JPH0725694B2 (ja) 1995-03-22

Similar Documents

Publication Publication Date Title
ES2106785T3 (es) Medicamentos, su preparacion y empleo como analgesicos y/o antiinflamatorios para seres humanos y animales.
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
FI904445A0 (fi) Antivirala foereningar.
DK184186D0 (da) Terapeutisk praeparat til behandling af virussygdomme
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
UY27948A1 (es) Vacunas para enfermedades reproductoras del ganado
SE8703066D0 (sv) Antiseptic composition containing ethyl alcohol and monolaurin
ATE20309T1 (de) Pharmazeutische zubereitung.
AR017877A1 (es) Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
AR041891A1 (es) Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza
ES2053585T3 (es) Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
CO4520283A1 (es) Agentes antivirales
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
CN101869601B (zh) 一种外用兽药
PT1156791E (pt) Bupropiona para tratar doencas virais
Balemual Review on pathogenesis, economic significance, prevention and controls of foot and mouth disease
ES2052579T3 (es) Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.
CN103550194A (zh) 一种外用兽药
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
Levin, S., Measroch, V., Pech, W. & Malherbe Hand-foot-and-mouth disease
SU198345A1 (ru) Лекарственный препарат
Thompson et al. Infectious bovine rhinotracheitis
Lunagariya et al. Management of Bovine ephemeral fever in crossbred cattle
CA1078737A (en) Process for the treatment and prevention of hoof and mouth disease in animals

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271447

Country of ref document: ES